Search results
French, US drug firms team up for Covid-flu shot
AFP via Yahoo Finance· 1 day agoFrench pharmaceutical giant Sanofi and struggling US rival Novavax announced Friday an alliance to sell a Covid vaccine and develop another that combines...
Sanofi reaches agreement with Novavax regarding COVID-19 vaccine
WFMZ Eastern Pennsylvania and Western New Jersey· 19 hours agoThe agreement involves co-commercializing the COVID-19 vaccine, developing novel COVID-19-Influenza...
Novavax signs multibillion-dollar deal with Sanofi to commercialize Covid vaccine, develop...
CNBC· 1 day agoA health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization...
Some Breather For Novavax's COVID-19 Vaccine, Inks Multibillion-Dollar Deal With Sanofi And Erases...
Benzinga· 1 day agoNovavax has a sole license to its adjuvanted COVID-19 vaccine for use in combination with Sanofi’s...
Novavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal
Bloomberg via Yahoo Finance· 1 day ago(Bloomberg) -- Novavax Inc. shares surged after the company signed a $1.2 billion licensing...
Novavax stock doubles after Sanofi deal marks 'new chapter' for company
Yahoo Finance via AOL· 19 hours agoWhile Novavax's vaccine did finally reach the market in mid-2022 targeting the booster market, it...
Novavax stock skyrockets 120% on $1.2 billion vaccine deal with Sanofi
Quartz· 1 day agoVaccine-maker Novavax announced a $1.2 billion licensing partnership with French pharmaceutical...
Novavax, Sanofi Ink Deal to Commercialize COVID-19 Vaccine to Jointly Produce Combination Shots -...
EconoTimes· 1 day agoNovavax, Inc., a biotechnology company headquartered in Gaithersburg, Maryland, revealed on Friday,...
Novavax shares jump 40% on $1.2 billion licensing deal with Sanofi despite Q1 losses | Invezz
Invezz· 1 day agoNovavax (NASDAQ:NVAX) shares rocketed 40% in premarket trading Friday, driven not only by the...
Novavax shares soar on license deal with Sanofi at lofty valuation
Reuters· 18 hours ago, opens new tab for its COVID-19 vaccine in exchange for a stake that valued the U.S. biotech firm...